Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients ; volume:15 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-18 ; date:12.2017
World journal of surgical oncology ; 15, Heft 1 (10.10.2017), 1-18, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Dhir, Mashaal
- Contributor
-
Malhotra, Gautam K.
Sohal, Davendra P.S
Hein, Nicholas A.
Smith, Lynette M.
O’Reilly, Eileen M.
Bahary, Nathan
Are, Chandrakanth
SpringerLink (Online service)
- DOI
-
10.1186/s12957-017-1240-2
- URN
-
urn:nbn:de:1111-201711156169
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dhir, Mashaal
- Malhotra, Gautam K.
- Sohal, Davendra P.S
- Hein, Nicholas A.
- Smith, Lynette M.
- O’Reilly, Eileen M.
- Bahary, Nathan
- Are, Chandrakanth
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
5520
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma
5520 Nidda
TGL 5520
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
5520
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma
5520 Nidda
TGL 5520
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
5520
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma
5520 Nidda